CMS advises on the sale of Haselmeier Group to Sulzer
The shareholders of Haselmeier Group, founded in 1920 and headquartered in St. Gallen, sold all shares in Haselmeier Group for an enterprise value of 100 million Euros to stock exchange listed Swiss company Sulzer. The transaction has been completed on 1 October 2020 in Zurich.
By acquiring Haselmeier, Sulzer will complement its healthcare portfolio and strengthen its applicator systems division. Together with Sulzer’s financial strength and know-how in precision injection moulding, the company will seize growth opportunities in the rapidly increasing drug delivery devices market.
In addition, combining Sulzer’s expertise in liquid mixing applications with Haselmeier’s drug delivery competence will benefit Sulzer’s pharmaceutical customers by providing them with innovative and sophisticated devices and services.